Accessibility Statement Skip Navigation
  • PRNewswire.com
  • Resources
  • +91 22-69790010
  • Client Login
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please use Advanced Search to search all press releases.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +91 22-69790010 from 9 AM - 5:30 PM IST

    • Contact
    • Contact

      +91 22-69790010
      from 9 AM - 5:30 PM IST

  • Request More Information
  • Journalists
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Request More Information
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Request More Information
  • Journalists
  • General Inquiries
  • Worldwide Offices
  • Request More Information
  • Journalists

NMIMS' School of Business Management Invites Applications For MBA in Pharmaceutical Management


News provided by

NMIMS Deemed to be University

27 Nov, 2020, 12:01 IST

Share this article

Share toX

Share this article

Share toX

The two-year course is among the best management courses in the pharmaceutical sector in the country, offering a multidimensional and comprehensive education on all aspects of the industry.

MUMBAI, India, Nov. 27, 2020 /PRNewswire/ -- SVKM's NMIMS' School of Business Management (SBM), a legacy institute known for its scholastic excellence, invites admissions for its highly sought-after MBA in Pharmaceuticals Management in Mumbai. Applications for the 2-years course are open till December 14. The carefully designed program is counted among the best in pharmaceutical management education with an impeccable reputation for academic achievements and placements.

As a leading global supplier of generic drugs, the Indian pharmaceutical industry was among the largest recruiters in the pre-COVID era. While recruitments had dropped in the immediate aftermath of the lockdown, it has since made a remarkable recovery in the last few months. Along with Fast Moving Consumer Goods, Information Technology, and education, the pharma industry has emerged as the main driver of the current economy. According to a job recruitment site, these sectors boosted hirings by over 24% in September when compared to August and is expected to increase further. With the healthcare sector projected to be one of the most important industries post-COVID, demand for management professionals specialising in the industry is expected to go up.

Speaking on the course, Dr. Ramesh Bhat, officiating Vice Chancellor SVKM's NMIMS, Provost and Dean, said, "NMIMS' MBA in Pharmaceuticals Management is one of the first of its kind in the country. Ever since we launched it 16 years ago, it has remained among the top courses in pharma industry management with a track record of 100 percent placements both for summer internships and final placements. Some of the eminent recruiters include Boston Scientific, Roche, AstraZeneca, Cognizant, Novartis, Cadila Pharmaceuticals, Dr Lal Path Labs, Tech Mahindra, Sun Pharma, etc."

The program is upgraded annually in consultation with industry experts to ensure that it remains contemporary. The MBA program is developed in consultation with industry heads and experts to ensure that students benefit from their practical knowledge. Apart from the institute-industry faculty alliance, the course is also carefully designed to ensure maximum on-field exposure for the students in order to broaden their knowledge of the industry. The domain-focused program help students hone their learning in every aspect of the industry. Students also have to take up one foreign language course, either Mandarin or Spanish.

Dr. Harikumar Iyer, Associate Professor, SBM, further added, "Our vision over the two years of the course is to immerse our students in this multidimensional and dynamic industry. What sets this course apart from any other MBA in the pharmaceutical field is our close association with the industry partners. This partnership has further helped us to hone our program among the best in the country today. For instance, this is the only MBA programme where students have to work for six months on a Brand Dissertation."

Past graduates of the MBA in Pharmaceutical Management are working in various roles in the industry, including Sales, Business Analyst, Project Management, Marketing, Client Servicing & Business development, International Marketing, and Operations. Among the pharma industries where management students are in high demand include Medical devices, Pharmaceuticals, Market Research, Consultancy, Diagnostics, Healthcare Communications, and Nutraceuticals.

Eligibility: Bachelor's or Master's Degree in; Pharmacy, Life Sciences, Medical Technology & Biotechnology, and MBBS, BDS, BHMS, BAMS from a recognised University with minimum 50% marks in the aggregate. Candidates with B.Tech. Bio-Tech./Bio-Medical or B.E. Bio-Tech./BioMedical from a recognised University with minimum 50% marks in the aggregate are also eligible to apply. Candidates working in Pharmaceutical Companies or with work experience in healthcare sector can also apply subject to meeting the above qualification criteria.

Registration process:

Step 1:  Register for NMAT by GMAC on www.nmat.org

Step 2:  Register and apply for NMIMS MBA at www.nmat.nmims.edu

For details on the programs, admission, eligibility, selection process and other information, visit www.nmims.edu

Accreditation: SBM has the prestigious Association to Advance Collegiate Schools of Business (AACSB) accreditation, which is known as the longest-standing and most prestigious professional accreditation in business education. It has NAAC accreditation with Grade A+ (3.59 CGPA), Mumbai Campus and is recognized as Category-I University by MHRD/UGC Grant of Graded Autonomy Regulation, 2018.

About NMIMS' SBM:

SBM of SVKM's NMIMS, Deemed-to-be-University, is  one of India's leading business schools with a legacy of world-renowned faculty and excellent placement program. NMIMS which began as a business school 40 years ago, is known for its trailblazing curriculum. The school has consistently ranked among the top 10 B-Schools in the country since 1998, in various such published surveys. 

About NMAT by GMAC™

The Graduate Management Admission Council (GMAC) owns and administers the NMAT by GMAC™ exam. The NMAT by GMAC™ is accepted by 38 leading institutions in India for securing admissions to their flagship MBA and other management programmes in India. Besides India, the NMAT by GMAC™ exam today is delivered across 12 countries namely, South Africa, Philippines, Nigeria, Bangladesh, Bhutan, Botswana, Nepal, Sri Lanka, UAE, Zimbabwe and Ethiopia. 

This year GMAC has introduced two types of testing modes for the exam. One is online proctored exam that can be taken from home and the second is the centre-based online exam. Candidates have the option to take the test either at test centre that follows all the social distancing protocols or take the online proctored exam from the comfort of their homes.

For more details, please visit www.nmims.edu

Modal title

Contact PR Newswire

  • +91 22-69790010

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+91 (0) 22 6169 6000
from 9 AM - 5:30 PM IST
  • Terms of Use
  • Privacy Policy
  • GDPR
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2025 Cision US Inc.